Patent · US Active

Use of R(+)-alpha-lipoic acid for cryptogenic neuropathy

US8722013B2 · kind B2 · utility

0Cited by

2References

17Claims

0Family size

Assignee

Encrypta GmbH · DE

Inventor

Klaus Wessel · Frankfurt, DE

Key dates

Filing date	Aug 14, 2008
Grant date	May 13, 2014
Priority date	—
Expiry date	Sep 10, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of R(+)-alpha-lipoic acid ((R)-5-(1,2-dithiolan-3-yl)valeric acid) and/or of a physiologically acceptable derivative of this compound for cryptogenic neuropathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.